According to IMARC Group latest report titled” Global Biopharmaceutical Market Report and Forecast 2021-2026”, the market is currently witnessing strong growth. The global Biopharmaceutical Market to exhibit moderate growth during the next five years. Biopharmaceuticals are biologically synthesized substances of high therapeutic value obtained from living organisms, such as microorganisms and animal cells. These large and complex molecular drugs are also known as biologics or biotech drugs. They mainly include monoclonal antibodies, recombinant growth factors, purified proteins, recombinant hormones, vaccines, synthetic immunomodulators, etc., utilized for therapeutic or in vivo diagnostic purposes. Biopharmaceuticals find extensive applications pertaining to autoimmune disorders, inflammatory and infectious diseases, hormonal disorders, cardiovascular ailments, metabolic disorders, neurological diseases, etc.Get a sample copy of this Report: www.imarcgroup.com/biotechnology-industry/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
The expanding geriatric population, along with the rising prevalence of chronic diseases, is primarily driving the biopharmaceutical market across the globe. Moreover, their ability to attack targets beyond the reach of traditional small molecule drugs is further contributing to the adoption of these biologics in the treatment of various life-threatening diseases. Additionally, increasing strategic collaborations among biopharmaceutical companies and rising investments in R&D activities are further bolstering the market growth. Moreover, the ongoing COVID-19 pandemic is leading to the development of vaccines against the SARS-CoV2 virus, some of which consist of advanced DNA, RNA, and protein subunit vaccines. Besides this, the rising need to alleviate the side effects of various small-molecule therapeutics and invasive surgical treatments will continue to drive the market growth over the forecast period.
View Full Report with TOC & List of Figure: www.imarcgroup.com/biotechnology-industry
Competitive Landscape with Key players:
The global biopharmaceutical market is concentrated in nature with the presence of a small number of key players who compete in terms of prices and quality. Some of the leading players operating in the market are:
Roche
Amgen
Novo Nordisk
AbbVie
Sanofi SA
Johnson & Johnson
Pfizer
Merck & Co.
Lilly
Biogen Idec
Key highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.